Tackling Affordability with Direct-to-Patient Sales Blog Post

Joshua Berus, PhD 2025年4月11日 Accessing affordable healthcare is one of the biggest challenges U.S. patients face. Historically, the pharmaceutical industry has relied on traditional distribution models, but this...

How Certara MIDD Experts Overcame Client Regulatory Challenges Blog Post

Certara’s Model-Informed Drug Development (MIDD) approach leverages an integrated, quantitative systems methodology to accelerate regulatory approval and commercial success while minimizing time and costs. With a global team of 700+...